nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.179	0.251	CbGbCtD
Sitagliptin—CYP2C8—Progesterone—uterine cancer	0.119	0.167	CbGbCtD
Sitagliptin—ABCB1—Progesterone—uterine cancer	0.0803	0.113	CbGbCtD
Sitagliptin—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0726	0.102	CbGbCtD
Sitagliptin—ABCB1—Dactinomycin—uterine cancer	0.0637	0.0894	CbGbCtD
Sitagliptin—CYP2C8—Etoposide—uterine cancer	0.0531	0.0745	CbGbCtD
Sitagliptin—CYP3A4—Progesterone—uterine cancer	0.0481	0.0676	CbGbCtD
Sitagliptin—ABCB1—Etoposide—uterine cancer	0.0359	0.0505	CbGbCtD
Sitagliptin—ABCB1—Doxorubicin—uterine cancer	0.0245	0.0344	CbGbCtD
Sitagliptin—CYP3A4—Etoposide—uterine cancer	0.0215	0.0302	CbGbCtD
Sitagliptin—CYP3A4—Doxorubicin—uterine cancer	0.0147	0.0206	CbGbCtD
Sitagliptin—DPP4—exocrine gland—uterine cancer	0.00783	0.138	CbGeAlD
Sitagliptin—DPP4—epithelium—uterine cancer	0.00341	0.0598	CbGeAlD
Sitagliptin—DPP4—uterine cervix—uterine cancer	0.00338	0.0593	CbGeAlD
Sitagliptin—DPP4—smooth muscle tissue—uterine cancer	0.00328	0.0576	CbGeAlD
Sitagliptin—DPP4—decidua—uterine cancer	0.00322	0.0565	CbGeAlD
Sitagliptin—DPP4—renal system—uterine cancer	0.00316	0.0555	CbGeAlD
Sitagliptin—DPP4—endometrium—uterine cancer	0.00306	0.0536	CbGeAlD
Sitagliptin—DPP4—mammalian vulva—uterine cancer	0.00296	0.0519	CbGeAlD
Sitagliptin—DPP4—uterus—uterine cancer	0.00282	0.0494	CbGeAlD
Sitagliptin—DPP4—female reproductive system—uterine cancer	0.00253	0.0444	CbGeAlD
Sitagliptin—DPP4—female gonad—uterine cancer	0.0023	0.0404	CbGeAlD
Sitagliptin—DPP4—vagina—uterine cancer	0.00229	0.0402	CbGeAlD
Sitagliptin—CYP2C8—renal system—uterine cancer	0.00152	0.0267	CbGeAlD
Sitagliptin—DPP4—lymph node—uterine cancer	0.00148	0.026	CbGeAlD
Sitagliptin—CYP2C8—endometrium—uterine cancer	0.00147	0.0258	CbGeAlD
Sitagliptin—CYP2C8—female reproductive system—uterine cancer	0.00122	0.0214	CbGeAlD
Sitagliptin—CYP2C8—vagina—uterine cancer	0.0011	0.0194	CbGeAlD
Sitagliptin—CYP3A4—renal system—uterine cancer	0.00103	0.0181	CbGeAlD
Sitagliptin—ABCB1—myometrium—uterine cancer	0.001	0.0176	CbGeAlD
Sitagliptin—CYP3A4—female reproductive system—uterine cancer	0.000826	0.0145	CbGeAlD
Sitagliptin—ABCB1—epithelium—uterine cancer	0.000787	0.0138	CbGeAlD
Sitagliptin—ABCB1—uterine cervix—uterine cancer	0.00078	0.0137	CbGeAlD
Sitagliptin—ABCB1—decidua—uterine cancer	0.000743	0.013	CbGeAlD
Sitagliptin—ABCB1—renal system—uterine cancer	0.00073	0.0128	CbGeAlD
Sitagliptin—ABCB1—endometrium—uterine cancer	0.000705	0.0124	CbGeAlD
Sitagliptin—ABCB1—mammalian vulva—uterine cancer	0.000682	0.012	CbGeAlD
Sitagliptin—ABCB1—uterus—uterine cancer	0.00065	0.0114	CbGeAlD
Sitagliptin—ABCB1—female reproductive system—uterine cancer	0.000584	0.0103	CbGeAlD
Sitagliptin—ABCB1—female gonad—uterine cancer	0.000532	0.00933	CbGeAlD
Sitagliptin—ABCB1—vagina—uterine cancer	0.000529	0.00928	CbGeAlD
Sitagliptin—Musculoskeletal pain—Doxorubicin—uterine cancer	0.000514	0.00223	CcSEcCtD
Sitagliptin—Neck pain—Doxorubicin—uterine cancer	0.000514	0.00223	CcSEcCtD
Sitagliptin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00051	0.00221	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000506	0.00219	CcSEcCtD
Sitagliptin—Myalgia—Dactinomycin—uterine cancer	0.000503	0.00218	CcSEcCtD
Sitagliptin—Hypersensitivity—Progesterone—uterine cancer	0.000503	0.00218	CcSEcCtD
Sitagliptin—Discomfort—Dactinomycin—uterine cancer	0.000497	0.00215	CcSEcCtD
Sitagliptin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000492	0.00213	CcSEcCtD
Sitagliptin—Asthenia—Progesterone—uterine cancer	0.00049	0.00212	CcSEcCtD
Sitagliptin—Hypoaesthesia—Etoposide—uterine cancer	0.000489	0.00212	CcSEcCtD
Sitagliptin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000489	0.00212	CcSEcCtD
Sitagliptin—Urinary tract disorder—Etoposide—uterine cancer	0.000486	0.0021	CcSEcCtD
Sitagliptin—Urethral disorder—Etoposide—uterine cancer	0.000482	0.00209	CcSEcCtD
Sitagliptin—Infection—Dactinomycin—uterine cancer	0.000479	0.00208	CcSEcCtD
Sitagliptin—Diarrhoea—Progesterone—uterine cancer	0.000467	0.00202	CcSEcCtD
Sitagliptin—Erythema multiforme—Etoposide—uterine cancer	0.000465	0.00201	CcSEcCtD
Sitagliptin—Eye disorder—Etoposide—uterine cancer	0.000459	0.00199	CcSEcCtD
Sitagliptin—Cardiac disorder—Etoposide—uterine cancer	0.000456	0.00198	CcSEcCtD
Sitagliptin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000456	0.00197	CcSEcCtD
Sitagliptin—Dizziness—Progesterone—uterine cancer	0.000452	0.00196	CcSEcCtD
Sitagliptin—Angiopathy—Etoposide—uterine cancer	0.000446	0.00193	CcSEcCtD
Sitagliptin—Immune system disorder—Etoposide—uterine cancer	0.000444	0.00192	CcSEcCtD
Sitagliptin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000444	0.00192	CcSEcCtD
Sitagliptin—Eczema—Epirubicin—uterine cancer	0.000443	0.00192	CcSEcCtD
Sitagliptin—Mediastinal disorder—Etoposide—uterine cancer	0.000443	0.00192	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00044	0.0019	CcSEcCtD
Sitagliptin—Vomiting—Progesterone—uterine cancer	0.000434	0.00188	CcSEcCtD
Sitagliptin—Renal failure acute—Epirubicin—uterine cancer	0.000431	0.00187	CcSEcCtD
Sitagliptin—Rash—Progesterone—uterine cancer	0.000431	0.00186	CcSEcCtD
Sitagliptin—Dermatitis—Progesterone—uterine cancer	0.00043	0.00186	CcSEcCtD
Sitagliptin—Headache—Progesterone—uterine cancer	0.000428	0.00185	CcSEcCtD
Sitagliptin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000423	0.00183	CcSEcCtD
Sitagliptin—Decreased appetite—Dactinomycin—uterine cancer	0.00042	0.00182	CcSEcCtD
Sitagliptin—Renal impairment—Epirubicin—uterine cancer	0.000419	0.00181	CcSEcCtD
Sitagliptin—Fatigue—Dactinomycin—uterine cancer	0.000416	0.0018	CcSEcCtD
Sitagliptin—Back pain—Etoposide—uterine cancer	0.000414	0.00179	CcSEcCtD
Sitagliptin—Pain—Dactinomycin—uterine cancer	0.000413	0.00179	CcSEcCtD
Sitagliptin—Muscle spasms—Etoposide—uterine cancer	0.000411	0.00178	CcSEcCtD
Sitagliptin—Eczema—Doxorubicin—uterine cancer	0.00041	0.00178	CcSEcCtD
Sitagliptin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000409	0.00177	CcSEcCtD
Sitagliptin—Hypoglycaemia—Epirubicin—uterine cancer	0.000408	0.00177	CcSEcCtD
Sitagliptin—Nausea—Progesterone—uterine cancer	0.000406	0.00176	CcSEcCtD
Sitagliptin—Renal failure acute—Doxorubicin—uterine cancer	0.000399	0.00173	CcSEcCtD
Sitagliptin—Osteoarthritis—Epirubicin—uterine cancer	0.000398	0.00173	CcSEcCtD
Sitagliptin—Pain in extremity—Epirubicin—uterine cancer	0.000398	0.00173	CcSEcCtD
Sitagliptin—Feeling abnormal—Dactinomycin—uterine cancer	0.000398	0.00172	CcSEcCtD
Sitagliptin—Ill-defined disorder—Etoposide—uterine cancer	0.000397	0.00172	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000395	0.00171	CcSEcCtD
Sitagliptin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000393	0.0017	CcSEcCtD
Sitagliptin—Migraine—Epirubicin—uterine cancer	0.000392	0.0017	CcSEcCtD
Sitagliptin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00039	0.00169	CcSEcCtD
Sitagliptin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00039	0.00169	CcSEcCtD
Sitagliptin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000388	0.00168	CcSEcCtD
Sitagliptin—Renal impairment—Doxorubicin—uterine cancer	0.000387	0.00168	CcSEcCtD
Sitagliptin—Malaise—Etoposide—uterine cancer	0.000386	0.00167	CcSEcCtD
Sitagliptin—Face oedema—Epirubicin—uterine cancer	0.000385	0.00167	CcSEcCtD
Sitagliptin—Vertigo—Etoposide—uterine cancer	0.000385	0.00167	CcSEcCtD
Sitagliptin—Abdominal pain—Dactinomycin—uterine cancer	0.000382	0.00165	CcSEcCtD
Sitagliptin—Hypoglycaemia—Doxorubicin—uterine cancer	0.000378	0.00164	CcSEcCtD
Sitagliptin—Cough—Etoposide—uterine cancer	0.000373	0.00162	CcSEcCtD
Sitagliptin—Blood creatinine increased—Epirubicin—uterine cancer	0.000373	0.00162	CcSEcCtD
Sitagliptin—Hypertension—Etoposide—uterine cancer	0.000369	0.0016	CcSEcCtD
Sitagliptin—Osteoarthritis—Doxorubicin—uterine cancer	0.000369	0.0016	CcSEcCtD
Sitagliptin—Pain in extremity—Doxorubicin—uterine cancer	0.000369	0.0016	CcSEcCtD
Sitagliptin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000368	0.00159	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Epirubicin—uterine cancer	0.000364	0.00158	CcSEcCtD
Sitagliptin—Abdominal pain upper—Epirubicin—uterine cancer	0.000364	0.00158	CcSEcCtD
Sitagliptin—Migraine—Doxorubicin—uterine cancer	0.000363	0.00157	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000362	0.00157	CcSEcCtD
Sitagliptin—Discomfort—Etoposide—uterine cancer	0.00036	0.00156	CcSEcCtD
Sitagliptin—Breast disorder—Epirubicin—uterine cancer	0.00036	0.00156	CcSEcCtD
Sitagliptin—Nasopharyngitis—Epirubicin—uterine cancer	0.000356	0.00154	CcSEcCtD
Sitagliptin—Face oedema—Doxorubicin—uterine cancer	0.000356	0.00154	CcSEcCtD
Sitagliptin—Hypersensitivity—Dactinomycin—uterine cancer	0.000356	0.00154	CcSEcCtD
Sitagliptin—Anaphylactic shock—Etoposide—uterine cancer	0.000349	0.00151	CcSEcCtD
Sitagliptin—Infection—Etoposide—uterine cancer	0.000347	0.0015	CcSEcCtD
Sitagliptin—Asthenia—Dactinomycin—uterine cancer	0.000346	0.0015	CcSEcCtD
Sitagliptin—Blood creatinine increased—Doxorubicin—uterine cancer	0.000345	0.0015	CcSEcCtD
Sitagliptin—Influenza—Epirubicin—uterine cancer	0.000344	0.00149	CcSEcCtD
Sitagliptin—ABCB1—lymph node—uterine cancer	0.000342	0.006	CbGeAlD
Sitagliptin—Skin disorder—Etoposide—uterine cancer	0.000339	0.00147	CcSEcCtD
Sitagliptin—Pancreatitis—Epirubicin—uterine cancer	0.000338	0.00146	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000337	0.00146	CcSEcCtD
Sitagliptin—Abdominal pain upper—Doxorubicin—uterine cancer	0.000337	0.00146	CcSEcCtD
Sitagliptin—Breast disorder—Doxorubicin—uterine cancer	0.000333	0.00144	CcSEcCtD
Sitagliptin—Bronchitis—Epirubicin—uterine cancer	0.000331	0.00143	CcSEcCtD
Sitagliptin—Diarrhoea—Dactinomycin—uterine cancer	0.00033	0.00143	CcSEcCtD
Sitagliptin—Nasopharyngitis—Doxorubicin—uterine cancer	0.00033	0.00143	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Epirubicin—uterine cancer	0.00032	0.00139	CcSEcCtD
Sitagliptin—Influenza—Doxorubicin—uterine cancer	0.000319	0.00138	CcSEcCtD
Sitagliptin—Weight increased—Epirubicin—uterine cancer	0.000313	0.00136	CcSEcCtD
Sitagliptin—Pancreatitis—Doxorubicin—uterine cancer	0.000312	0.00135	CcSEcCtD
Sitagliptin—Hyperglycaemia—Epirubicin—uterine cancer	0.000311	0.00135	CcSEcCtD
Sitagliptin—Somnolence—Etoposide—uterine cancer	0.000311	0.00135	CcSEcCtD
Sitagliptin—Pneumonia—Epirubicin—uterine cancer	0.000309	0.00134	CcSEcCtD
Sitagliptin—Infestation NOS—Epirubicin—uterine cancer	0.000307	0.00133	CcSEcCtD
Sitagliptin—Infestation—Epirubicin—uterine cancer	0.000307	0.00133	CcSEcCtD
Sitagliptin—Vomiting—Dactinomycin—uterine cancer	0.000307	0.00133	CcSEcCtD
Sitagliptin—Bronchitis—Doxorubicin—uterine cancer	0.000306	0.00133	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000304	0.00132	CcSEcCtD
Sitagliptin—Rash—Dactinomycin—uterine cancer	0.000304	0.00132	CcSEcCtD
Sitagliptin—Decreased appetite—Etoposide—uterine cancer	0.000304	0.00132	CcSEcCtD
Sitagliptin—Renal failure—Epirubicin—uterine cancer	0.000302	0.00131	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Etoposide—uterine cancer	0.000302	0.00131	CcSEcCtD
Sitagliptin—Fatigue—Etoposide—uterine cancer	0.000301	0.0013	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Epirubicin—uterine cancer	0.000301	0.0013	CcSEcCtD
Sitagliptin—Pain—Etoposide—uterine cancer	0.000299	0.00129	CcSEcCtD
Sitagliptin—Constipation—Etoposide—uterine cancer	0.000299	0.00129	CcSEcCtD
Sitagliptin—Urinary tract infection—Epirubicin—uterine cancer	0.000298	0.00129	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000296	0.00128	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Epirubicin—uterine cancer	0.00029	0.00126	CcSEcCtD
Sitagliptin—Weight increased—Doxorubicin—uterine cancer	0.00029	0.00126	CcSEcCtD
Sitagliptin—Sinusitis—Epirubicin—uterine cancer	0.000288	0.00125	CcSEcCtD
Sitagliptin—Feeling abnormal—Etoposide—uterine cancer	0.000288	0.00125	CcSEcCtD
Sitagliptin—Hyperglycaemia—Doxorubicin—uterine cancer	0.000287	0.00124	CcSEcCtD
Sitagliptin—Nausea—Dactinomycin—uterine cancer	0.000287	0.00124	CcSEcCtD
Sitagliptin—Pneumonia—Doxorubicin—uterine cancer	0.000286	0.00124	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Etoposide—uterine cancer	0.000286	0.00124	CcSEcCtD
Sitagliptin—Infestation NOS—Doxorubicin—uterine cancer	0.000284	0.00123	CcSEcCtD
Sitagliptin—Infestation—Doxorubicin—uterine cancer	0.000284	0.00123	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000282	0.00122	CcSEcCtD
Sitagliptin—Renal failure—Doxorubicin—uterine cancer	0.000279	0.00121	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000278	0.00121	CcSEcCtD
Sitagliptin—Urticaria—Etoposide—uterine cancer	0.000277	0.0012	CcSEcCtD
Sitagliptin—Abdominal pain—Etoposide—uterine cancer	0.000276	0.0012	CcSEcCtD
Sitagliptin—Urinary tract infection—Doxorubicin—uterine cancer	0.000276	0.0012	CcSEcCtD
Sitagliptin—Hypoaesthesia—Epirubicin—uterine cancer	0.000274	0.00119	CcSEcCtD
Sitagliptin—Pharyngitis—Epirubicin—uterine cancer	0.000274	0.00118	CcSEcCtD
Sitagliptin—Urinary tract disorder—Epirubicin—uterine cancer	0.000272	0.00118	CcSEcCtD
Sitagliptin—Oedema peripheral—Epirubicin—uterine cancer	0.000271	0.00118	CcSEcCtD
Sitagliptin—Connective tissue disorder—Epirubicin—uterine cancer	0.000271	0.00117	CcSEcCtD
Sitagliptin—Urethral disorder—Epirubicin—uterine cancer	0.00027	0.00117	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000269	0.00116	CcSEcCtD
Sitagliptin—Sinusitis—Doxorubicin—uterine cancer	0.000266	0.00115	CcSEcCtD
Sitagliptin—Erythema multiforme—Epirubicin—uterine cancer	0.000261	0.00113	CcSEcCtD
Sitagliptin—Eye disorder—Epirubicin—uterine cancer	0.000258	0.00112	CcSEcCtD
Sitagliptin—Hypersensitivity—Etoposide—uterine cancer	0.000257	0.00111	CcSEcCtD
Sitagliptin—Cardiac disorder—Epirubicin—uterine cancer	0.000256	0.00111	CcSEcCtD
Sitagliptin—Hypoaesthesia—Doxorubicin—uterine cancer	0.000254	0.0011	CcSEcCtD
Sitagliptin—Pharyngitis—Doxorubicin—uterine cancer	0.000253	0.0011	CcSEcCtD
Sitagliptin—Urinary tract disorder—Doxorubicin—uterine cancer	0.000252	0.00109	CcSEcCtD
Sitagliptin—Oedema peripheral—Doxorubicin—uterine cancer	0.000251	0.00109	CcSEcCtD
Sitagliptin—Asthenia—Etoposide—uterine cancer	0.000251	0.00109	CcSEcCtD
Sitagliptin—Connective tissue disorder—Doxorubicin—uterine cancer	0.000251	0.00109	CcSEcCtD
Sitagliptin—Angiopathy—Epirubicin—uterine cancer	0.00025	0.00108	CcSEcCtD
Sitagliptin—Urethral disorder—Doxorubicin—uterine cancer	0.00025	0.00108	CcSEcCtD
Sitagliptin—Immune system disorder—Epirubicin—uterine cancer	0.000249	0.00108	CcSEcCtD
Sitagliptin—Mediastinal disorder—Epirubicin—uterine cancer	0.000248	0.00108	CcSEcCtD
Sitagliptin—Mental disorder—Epirubicin—uterine cancer	0.000241	0.00105	CcSEcCtD
Sitagliptin—Erythema multiforme—Doxorubicin—uterine cancer	0.000241	0.00104	CcSEcCtD
Sitagliptin—Malnutrition—Epirubicin—uterine cancer	0.00024	0.00104	CcSEcCtD
Sitagliptin—Diarrhoea—Etoposide—uterine cancer	0.000239	0.00104	CcSEcCtD
Sitagliptin—Eye disorder—Doxorubicin—uterine cancer	0.000238	0.00103	CcSEcCtD
Sitagliptin—Cardiac disorder—Doxorubicin—uterine cancer	0.000237	0.00103	CcSEcCtD
Sitagliptin—Flatulence—Epirubicin—uterine cancer	0.000236	0.00102	CcSEcCtD
Sitagliptin—Tension—Epirubicin—uterine cancer	0.000235	0.00102	CcSEcCtD
Sitagliptin—Nervousness—Epirubicin—uterine cancer	0.000233	0.00101	CcSEcCtD
Sitagliptin—Back pain—Epirubicin—uterine cancer	0.000232	0.00101	CcSEcCtD
Sitagliptin—Angiopathy—Doxorubicin—uterine cancer	0.000231	0.001	CcSEcCtD
Sitagliptin—Dizziness—Etoposide—uterine cancer	0.000231	0.001	CcSEcCtD
Sitagliptin—Muscle spasms—Epirubicin—uterine cancer	0.000231	0.000999	CcSEcCtD
Sitagliptin—Immune system disorder—Doxorubicin—uterine cancer	0.00023	0.000998	CcSEcCtD
Sitagliptin—Mediastinal disorder—Doxorubicin—uterine cancer	0.00023	0.000995	CcSEcCtD
Sitagliptin—Vision blurred—Epirubicin—uterine cancer	0.000226	0.000979	CcSEcCtD
Sitagliptin—Mental disorder—Doxorubicin—uterine cancer	0.000223	0.000968	CcSEcCtD
Sitagliptin—Ill-defined disorder—Epirubicin—uterine cancer	0.000223	0.000964	CcSEcCtD
Sitagliptin—Vomiting—Etoposide—uterine cancer	0.000222	0.000962	CcSEcCtD
Sitagliptin—Malnutrition—Doxorubicin—uterine cancer	0.000222	0.000962	CcSEcCtD
Sitagliptin—Rash—Etoposide—uterine cancer	0.00022	0.000954	CcSEcCtD
Sitagliptin—Dermatitis—Etoposide—uterine cancer	0.00022	0.000953	CcSEcCtD
Sitagliptin—Headache—Etoposide—uterine cancer	0.000219	0.000948	CcSEcCtD
Sitagliptin—Flatulence—Doxorubicin—uterine cancer	0.000219	0.000947	CcSEcCtD
Sitagliptin—Tension—Doxorubicin—uterine cancer	0.000218	0.000944	CcSEcCtD
Sitagliptin—Malaise—Epirubicin—uterine cancer	0.000216	0.000937	CcSEcCtD
Sitagliptin—Nervousness—Doxorubicin—uterine cancer	0.000216	0.000934	CcSEcCtD
Sitagliptin—Vertigo—Epirubicin—uterine cancer	0.000216	0.000934	CcSEcCtD
Sitagliptin—Back pain—Doxorubicin—uterine cancer	0.000215	0.00093	CcSEcCtD
Sitagliptin—Muscle spasms—Doxorubicin—uterine cancer	0.000213	0.000924	CcSEcCtD
Sitagliptin—Cough—Epirubicin—uterine cancer	0.000209	0.000907	CcSEcCtD
Sitagliptin—Vision blurred—Doxorubicin—uterine cancer	0.000209	0.000906	CcSEcCtD
Sitagliptin—Nausea—Etoposide—uterine cancer	0.000207	0.000899	CcSEcCtD
Sitagliptin—Hypertension—Epirubicin—uterine cancer	0.000207	0.000897	CcSEcCtD
Sitagliptin—Ill-defined disorder—Doxorubicin—uterine cancer	0.000206	0.000892	CcSEcCtD
Sitagliptin—Myalgia—Epirubicin—uterine cancer	0.000204	0.000885	CcSEcCtD
Sitagliptin—Arthralgia—Epirubicin—uterine cancer	0.000204	0.000885	CcSEcCtD
Sitagliptin—Anxiety—Epirubicin—uterine cancer	0.000204	0.000882	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000203	0.000879	CcSEcCtD
Sitagliptin—Discomfort—Epirubicin—uterine cancer	0.000202	0.000874	CcSEcCtD
Sitagliptin—Malaise—Doxorubicin—uterine cancer	0.0002	0.000867	CcSEcCtD
Sitagliptin—Dry mouth—Epirubicin—uterine cancer	0.0002	0.000865	CcSEcCtD
Sitagliptin—Vertigo—Doxorubicin—uterine cancer	0.000199	0.000864	CcSEcCtD
Sitagliptin—Anaphylactic shock—Epirubicin—uterine cancer	0.000196	0.000848	CcSEcCtD
Sitagliptin—Infection—Epirubicin—uterine cancer	0.000195	0.000843	CcSEcCtD
Sitagliptin—Cough—Doxorubicin—uterine cancer	0.000194	0.000839	CcSEcCtD
Sitagliptin—Nervous system disorder—Epirubicin—uterine cancer	0.000192	0.000832	CcSEcCtD
Sitagliptin—Hypertension—Doxorubicin—uterine cancer	0.000192	0.00083	CcSEcCtD
Sitagliptin—Skin disorder—Epirubicin—uterine cancer	0.00019	0.000824	CcSEcCtD
Sitagliptin—Myalgia—Doxorubicin—uterine cancer	0.000189	0.000819	CcSEcCtD
Sitagliptin—Arthralgia—Doxorubicin—uterine cancer	0.000189	0.000819	CcSEcCtD
Sitagliptin—Anxiety—Doxorubicin—uterine cancer	0.000188	0.000816	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000188	0.000813	CcSEcCtD
Sitagliptin—Discomfort—Doxorubicin—uterine cancer	0.000187	0.000809	CcSEcCtD
Sitagliptin—Dry mouth—Doxorubicin—uterine cancer	0.000185	0.000801	CcSEcCtD
Sitagliptin—Anaphylactic shock—Doxorubicin—uterine cancer	0.000181	0.000785	CcSEcCtD
Sitagliptin—Infection—Doxorubicin—uterine cancer	0.00018	0.00078	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000178	0.000773	CcSEcCtD
Sitagliptin—Nervous system disorder—Doxorubicin—uterine cancer	0.000178	0.00077	CcSEcCtD
Sitagliptin—Insomnia—Epirubicin—uterine cancer	0.000177	0.000767	CcSEcCtD
Sitagliptin—Skin disorder—Doxorubicin—uterine cancer	0.000176	0.000762	CcSEcCtD
Sitagliptin—Somnolence—Epirubicin—uterine cancer	0.000174	0.000754	CcSEcCtD
Sitagliptin—Dyspepsia—Epirubicin—uterine cancer	0.000172	0.000747	CcSEcCtD
Sitagliptin—Decreased appetite—Epirubicin—uterine cancer	0.00017	0.000737	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000169	0.000732	CcSEcCtD
Sitagliptin—Fatigue—Epirubicin—uterine cancer	0.000169	0.000731	CcSEcCtD
Sitagliptin—Pain—Epirubicin—uterine cancer	0.000167	0.000725	CcSEcCtD
Sitagliptin—Constipation—Epirubicin—uterine cancer	0.000167	0.000725	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000165	0.000715	CcSEcCtD
Sitagliptin—Insomnia—Doxorubicin—uterine cancer	0.000164	0.00071	CcSEcCtD
Sitagliptin—Feeling abnormal—Epirubicin—uterine cancer	0.000161	0.000699	CcSEcCtD
Sitagliptin—Somnolence—Doxorubicin—uterine cancer	0.000161	0.000698	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Epirubicin—uterine cancer	0.00016	0.000694	CcSEcCtD
Sitagliptin—Dyspepsia—Doxorubicin—uterine cancer	0.000159	0.000691	CcSEcCtD
Sitagliptin—Decreased appetite—Doxorubicin—uterine cancer	0.000157	0.000682	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000156	0.000678	CcSEcCtD
Sitagliptin—Fatigue—Doxorubicin—uterine cancer	0.000156	0.000677	CcSEcCtD
Sitagliptin—Urticaria—Epirubicin—uterine cancer	0.000156	0.000674	CcSEcCtD
Sitagliptin—Pain—Doxorubicin—uterine cancer	0.000155	0.000671	CcSEcCtD
Sitagliptin—Constipation—Doxorubicin—uterine cancer	0.000155	0.000671	CcSEcCtD
Sitagliptin—Abdominal pain—Epirubicin—uterine cancer	0.000155	0.00067	CcSEcCtD
Sitagliptin—Feeling abnormal—Doxorubicin—uterine cancer	0.000149	0.000647	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000148	0.000642	CcSEcCtD
Sitagliptin—Hypersensitivity—Epirubicin—uterine cancer	0.000144	0.000625	CcSEcCtD
Sitagliptin—Urticaria—Doxorubicin—uterine cancer	0.000144	0.000623	CcSEcCtD
Sitagliptin—Abdominal pain—Doxorubicin—uterine cancer	0.000143	0.00062	CcSEcCtD
Sitagliptin—Asthenia—Epirubicin—uterine cancer	0.00014	0.000609	CcSEcCtD
Sitagliptin—Diarrhoea—Epirubicin—uterine cancer	0.000134	0.00058	CcSEcCtD
Sitagliptin—Hypersensitivity—Doxorubicin—uterine cancer	0.000133	0.000578	CcSEcCtD
Sitagliptin—Asthenia—Doxorubicin—uterine cancer	0.00013	0.000563	CcSEcCtD
Sitagliptin—Dizziness—Epirubicin—uterine cancer	0.000129	0.000561	CcSEcCtD
Sitagliptin—Vomiting—Epirubicin—uterine cancer	0.000124	0.000539	CcSEcCtD
Sitagliptin—Diarrhoea—Doxorubicin—uterine cancer	0.000124	0.000537	CcSEcCtD
Sitagliptin—Rash—Epirubicin—uterine cancer	0.000123	0.000535	CcSEcCtD
Sitagliptin—Dermatitis—Epirubicin—uterine cancer	0.000123	0.000534	CcSEcCtD
Sitagliptin—Headache—Epirubicin—uterine cancer	0.000123	0.000531	CcSEcCtD
Sitagliptin—Dizziness—Doxorubicin—uterine cancer	0.00012	0.000519	CcSEcCtD
Sitagliptin—Nausea—Epirubicin—uterine cancer	0.000116	0.000504	CcSEcCtD
Sitagliptin—Vomiting—Doxorubicin—uterine cancer	0.000115	0.000499	CcSEcCtD
Sitagliptin—Rash—Doxorubicin—uterine cancer	0.000114	0.000495	CcSEcCtD
Sitagliptin—Dermatitis—Doxorubicin—uterine cancer	0.000114	0.000494	CcSEcCtD
Sitagliptin—Headache—Doxorubicin—uterine cancer	0.000113	0.000492	CcSEcCtD
Sitagliptin—Nausea—Doxorubicin—uterine cancer	0.000108	0.000466	CcSEcCtD
